brefanolol

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Hypertension (High Blood Pressure) 07/01/1990 - "Hemodynamic effects of brefanolol and propranolol assessed by noninvasive methods in patients with arterial hypertension." 07/01/1990 - "In a placebo-controlled, randomized, cross-over study, 16 patients (10 males, 6 females; 50.6 +/- 10.4 years; body weight of 74.5 +/- 8.9 kg; mean +/- SD) with arterial hypertension (WHO stages I and II) were administered single oral doses of placebo, 80 mg of propranolol, as well as 50 and 100 mg of brefanolol (a beta-adrenergic blocking agent with vasodilating properties) in order to determine the resulting hemodynamic effects. "
2.	Hyperemia 07/01/1990 - "Similar significant decreases in blood pressure, heart rate, and cardiac output also occurred with 50 mg of brefanolol, but stroke volume and reactive hyperemia increased. "
3.	Body Weight (Weight, Body) 07/01/1990 - "In a placebo-controlled, randomized, cross-over study, 16 patients (10 males, 6 females; 50.6 +/- 10.4 years; body weight of 74.5 +/- 8.9 kg; mean +/- SD) with arterial hypertension (WHO stages I and II) were administered single oral doses of placebo, 80 mg of propranolol, as well as 50 and 100 mg of brefanolol (a beta-adrenergic blocking agent with vasodilating properties) in order to determine the resulting hemodynamic effects. "

1.	Propranolol (Inderal)
2.	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)